Candidate gene
Marker
| biomarker for metastatic cancers, especially clear cell renal cell carcinoma | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | urinary | | |
might serve as a therapeutic target for clear cell renal cell carcinoma | cancer | endocrine | pancreas | |
molecules blocking the expression, phosphorylation, or the PRKCD-binding site of CDCP1 are potential therapeutic candidates for pancreatic cancer | cancer | lung | | |
novel target for treating cancer-specific disorders, such as metastasis, by regulating anoikis in lung adenocarcinoma | cancer | | | |
targeting of CDCP1 may be a rational approach to inhibit progression of cancers driven by EGFR signaling including those resistant to anti-EGFR drugs because of activating mutations in the RAS/RAF/MEK/ERK pathway | cancer | metastases | | |
potential therapeutic target for metastatic cancers |
| | |